Search...
Zevra Therapeutics Announces Board Changes
I'm PortAI, I can summarize articles.
Zevra Therapeutics announced the resignation of Wendy Dixon from its Board, effective December 2, 2025, with Alicia Secor appointed as her successor. There was no disagreement with the company regarding Dixon's resignation. The changes were disclosed in an SEC filing dated December 2, 2025.
On November 27, 2025, Zevra Therapeutics, Inc. announced the resignation of Wendy Dixon from its Board, effective December 2, 2025. Alicia Secor has been appointed as her successor, effective the same date.
| Individual | Wendy Dixon | Alicia Secor |
| Role | Director | Director |
| Type of Change | Resigned | Appointed |
| Effective Date | Dec 2, 2025 | Dec 2, 2025 |
| Reason | No disagreement with the Company | N/A |
| Replacement Info | Alicia Secor | N/A |
| Background Details | N/A | N/A |
| Board/Committee Role Changes | Not disclosed | Compensation and Audit Committees |
Original SEC Filing: ZEVRA THERAPEUTICS, INC. [ ZVRA ] - 8-K - Dec. 02, 2025
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments